No full text
Poster (Scientific congresses and symposiums)
Polytrimethylene Carbonate Nanoparticles formulation for drug delivery - A preliminary study
Baroni, Alexandra; Parumasivam, Thaigarajan; Abdelghany, Sharif et al.
2016Annual Meeting of the Belgian Polymer Group (BPG 2016)
 

Files


Full Text
No document available.
Annexes
2016_BPG_version ok.pdf
Publisher postprint (2.39 MB)
Request a copy
2016_BPG Abstract_Version finale.pdf
Publisher postprint (123.63 kB)
Download

All documents in ORBi UMONS are protected by a user license.

Send to



Details



Abstract :
[en] Over the past decade, the use of aliphatic polycarbonates has attracted increased attention in the field of drug delivery owing to their ability to form biocompatible nanocarriers that are safer and less toxic than viral ones and some synthetic gold standard polymers (e.g. poly(ethylenimine, PEI)[1]. Moreover, their fast biodegradability and resorbability occurring without the formation of acidic compounds make them more attractive than some aliphatic polyesters currently in use (e.g. PLA, PCL)[2]. Particularly, polytrimethylene carbonate (PTMC) is widely studied for soft tissue regeneration and functionalized micelles and hydrogels formation regarding its low glass transition temperature (~ - 20°C) and its hydrophobicity[3]. Its controlled and easy synthesis by ring-opening polymerization (ROP) of the commercially available trimethylene carbonate (TMC), using a metal-free and non-toxic catalyst[4], allows fast production of well-defined samples (dispersity, Ɖ ~1,1)[5]. This communication presents a preliminary study on nanoformulation of solid PTMC nanoparticles using the double emulsion - evaporation technique[6]. Its relevance for drug delivery was assessed by repeatability of the size and their ability to encapsulate a model ionisable drug, disodium cromoglycate, classically used for asthma treatment. Controlled PTMC-OH sample was produced according to a well-reported protocol[5] using DBU (1 Eq.) as catalyst, resulting in polymer chains characterized by an average molecular weight and a dispersity of Mn = 4.400 g/mol and Ɖ ~ 1,3, respectively. Nanoparticles were then produced by a double-emulsion evaporation technique involving 3 phases (w/o/w): i. an aqueous phase containing the drug dissolved in deionized (DI) water ; ii. an organic phase composed of PTMC dissolved in dichloromethane (DCM) ; iii. a second aqueous phase with polyvinyl alcohol (PVA) surfactant at 2,5 % (w/v) in DI water. Each sonication is achieved during 2 minutes (Pulse mode, Intensity 4, Cycle 20) in an ice bath. Nanoparticles size (Zsize ~ 180 nm) and zeta potential (ζpot ~ 0 mV) were measured by dynamic light scattering (DLS) and showed a good repeatability. Images were obtained with TEM. The entrapment efficiency (EE) of the drug was found to be around 15 % and was calculated by an indirect method using HPLC-UV (detector was set at 326 nm, separation was performed on a Luna C18 Column in isocratic mode with a monobasic potassium phosphate (0,025 M, pH 3.0) / Methanol (55/45 v/v) mixtures as mobile phase at 20 °C; flow rate = 1 mL/min). Through our approach, we have validated that this family of bioresorbable polymers offers great potential in the field of controlled drug release.   [1] J. Zhou, J. Liu, C. J. Cheng, T. R. Patel, C. E. Weller, J. M. Piepmeier, Z. Jiang, and W. M. Saltzman, 'Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery.,' Nat. Mater., vol. 11, no. 1, pp. 82-90, 2012. [2] Z. Zhang, R. Kuijer, S. K. Bulstra, D. W. Grijpma, and J. Feijen, 'The in vivo and in vitro degradation behavior of poly(trimethylene carbonate),' Biomaterials, vol. 27, no. 9, pp. 1741-1748, 2006. [3] K. Fukushima, 'Poly(trimethylene carbonate)-based polymers engineered for biodegradable functional biomaterials,' Biomater. Sci., vol. 4, no. 1, pp. 9-24, 2016. [4] A. Nachtergael, O. Coulembier, P. Dubois, M. Helvenstein, P. Duez, B. Blankert, and L. Mespouille, 'Organocatalysis paradigm revisited: Are metal-free catalysts really harmless?,' Biomacromolecules, vol. 16, no. 2, pp. 507-514, 2015. [5] F. a Leibfarth, B. G. G. Lohmeijer, F. Nederberg, C. Russell, J. W. Logan, R. M. Waymouth, and J. L. Hedrick, 'Organocatalytic Ring Opening Polymerization of Cyclic Monomers: Mechanistic and Synthetic Studies,' vol. 48, no. 1, pp. 984-985, 2007. [6] B. V. N. Nagavarma, H. K. S. Yadav, A. Ayaz, L. S. Vasudha, and H. G. Shivakumar, 'Different techniques for preparation of polymeric nanoparticles - a reviw,' Asian J. Pharm. Clin. Res., vol. 5, no. 3, pp. 16-23, 2012.
Research center :
CIRMAP - Centre d'Innovation et de Recherche en Matériaux Polymères
Disciplines :
Pharmacy, pharmacology & toxicology
Chemistry
Author, co-author :
Baroni, Alexandra ;  Université de Mons > Faculté de Médecine et de Pharmacie > Analyse pharmaceutique ; Université de Mons > Faculté des Sciences > Matériaux Polymères et Composites
Parumasivam, Thaigarajan
Abdelghany, Sharif
Dubois, Philippe  ;  Université de Mons > Faculté des Sciences > Matériaux Polymères et Composites
Blankert, Bertrand  ;  Université de Mons > Faculté de Médecine et de Pharmacie > Service d'Analyse pharmaceutique
Mespouille, Laetitia ;  Université de Mons > Faculté des Sciences > Matériaux Polymères et Composites
Chan, Hak-Kim
Language :
English
Title :
Polytrimethylene Carbonate Nanoparticles formulation for drug delivery - A preliminary study
Publication date :
23 May 2016
Number of pages :
1
Event name :
Annual Meeting of the Belgian Polymer Group (BPG 2016)
Event place :
Hasselt, Belgium
Event date :
2016
Research unit :
S816 - Matériaux Polymères et Composites
M130 - Analyse pharmaceutique
Research institute :
R550 - Institut des Sciences et Technologies de la Santé
Available on ORBi UMONS :
since 07 July 2016

Statistics


Number of views
14 (0 by UMONS)
Number of downloads
18 (0 by UMONS)

Bibliography


Similar publications



Contact ORBi UMONS